Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
AlphaRx received approval from the State FDA of China for...
Speaking at the ChinaBio® Investor Forum 2007...
KPMG released a 2008 venture capital forecast, drawn from...
AlphaRx will seek local partners with the goal of...
AlphaRx and Venturepharm China, a subsidiary of...
Xian-Janssen launched Dacogen, a myelodysplastic syndrome...
AlphaRx Inc. released details of its recently announced...
Access Pharma revealed plans for a China clinical trial...
AlphaRx announced that, as part of its China strategy, it...
The 7th ChinaBio® Investor Forum granted “Most...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
